In medicine, hope springs from research.
At Main Line Health, we believe research is essential for advancing health care, leading to medical breakthroughs that improve and save lives.
Our multidisciplinary clinical research teams offer a variety of trials in cancer, cardiovascular disease and other patient conditions. As a clinical research participant, you may have access to potential new treatments, cutting-edge health care choices and the opportunity to help advance medical knowledge.
Do you have questions about clinical research and clinical trials?
Our frequently asked questions page explains what clinical research is and provides more information about the different types of clinical trials, inclusion and exclusion criteria, consent forms, safety protocols and more.
Interested in learning more about immunotherapy?
LIMR’s President and CEO George Prendergast gave a talk on Facebook Live on May 17, 2018, highlighting the latest advances in research on immunotherapy, a new type of treatment option that harnesses the power of the patient's immune system to better target cancer cells.
Main Line Health is a member of the PIER Consortium
In addition to the clinical trials offered at Main Line Health, we offer patients access to a broader selection of clinical research being performed by the PIER Consortium™, a nonprofit, regional network of health care organizations. Main Line Health is a founding member of PIER, whose mission is so conduct cutting-edge clinical trials and foster innovation in clinical research. Founding Members include Atlantic Health System, Einstein Healthcare Network, Drexel University, Geisinger including AtlantiCare, Main Line Health, and Thomas Jefferson University.